메뉴 건너뛰기




Volumn 25, Issue 6, 1997, Pages 521-526

Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb®) for viral inactivation - Effect of crosslinking

Author keywords

[No Author keywords available]

Indexed keywords

CROSSLINKING; HEAT TREATMENT;

EID: 9844262799     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199709117449     Document Type: Article
Times cited : (9)

References (3)
  • 1
    • 0028142248 scopus 로고
    • Diaspirin Crosslinked Hemoglobin (DCLHb™): Characterization of the process and the product manufactured GMP requirements for clinical studies
    • Azari, M., Rohn, K., Picken, J., Diaspirin Crosslinked Hemoglobin (DCLHb™): Characterization of the process and the product manufactured GMP requirements for clinical studies (1994), Art., Blood Subs., and Immob. Biotech., 22(3), 701-708.
    • (1994) Art., Blood Subs., and Immob. Biotech. , vol.22 , Issue.3 , pp. 701-708
    • Azari, M.1    Rohn, K.2    Picken, J.3
  • 2
    • 0026759444 scopus 로고
    • Validation of Virus Inactivation by Heat Treatment in the Manufacture of Diaspirin Crosslinked Hemoglobin
    • Farmer, M., Ebeling, A., Marshall, T., Hauck, W., Sun, C.S., White, E., and Long, Z., Validation of Virus Inactivation by Heat Treatment in the Manufacture of Diaspirin Crosslinked Hemoglobin. Biomat Artif Cells Immobil Biotech 1992; 20(2-4), 429-433
    • (1992) Biomat Artif Cells Immobil Biotech , vol.20 , Issue.2-4 , pp. 429-433
    • Farmer, M.1    Ebeling, A.2    Marshall, T.3    Hauck, W.4    Sun, C.S.5    White, E.6    Long, Z.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.